Deals Shaping The Medtech Industry, February 2022
Executive Summary
Medtech Insight's Deal-Making column is a survey of recent health care transactions listed by relevant industry segment, in vitro diagnostics or medical devices, and then categorized by acquisition, alliance or financing. This month’s column covers deals announced in February 2022. Data provided by Biomedtracker.
You may also be interested in...
Concerns And Hopes For Health Care Delivery In 2024
Industry experts from Norstella, whose data and technologies support decision making from R&D through to market access, shared their worries going into 2024.
Health Equity Drives Small Molecule Strategy At Serna Bio
Serna Bio is using machine learning and RNA biology to create a platform for the discovery of small molecule modulators of RNA. The startup will seek fresh funding in 2024 and is on the hunt for creative biopharma partnerships.
The State Of TechBio Going Into 2024
The long-term success of TechBio is dependent upon the flow of investment and alliances with mature life sciences companies. This collaborative model has proven many times over to be an ideal framework to develop new treatments for patients.